{"id":"https://openalex.org/W37737972","doi":"https://doi.org/10.1007/978-1-4939-2143-0_4","title":"Clinical Utility of BRAF-Targeted Therapy in Melanoma","display_name":"Clinical Utility of BRAF-Targeted Therapy in Melanoma","publication_year":2014,"publication_date":"2014-11-25","ids":{"openalex":"https://openalex.org/W37737972","doi":"https://doi.org/10.1007/978-1-4939-2143-0_4","mag":"37737972"},"language":"en","primary_location":{"id":"doi:10.1007/978-1-4939-2143-0_4","doi":"https://doi.org/10.1007/978-1-4939-2143-0_4","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-1-4939-2143-0_4","pdf_url":null,"source":{"id":"https://openalex.org/S4210186866","display_name":"Cancer drug discovery and develogment/Cancer drug discovery and development","issn_l":"2196-9906","issn":["2196-9906","2196-9914"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20"],"host_organization":"https://openalex.org/P4310319972","host_organization_name":"Springer International Publishing","host_organization_lineage":["https://openalex.org/P4310319972","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer International Publishing","Springer Nature"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Drug Discovery and Development","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W2502057196","display_name":"BRAF Targets in Melanoma"},"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075566772","display_name":"Jeffrey Alan Sosman","orcid":"https://orcid.org/0000-0002-0650-9698","observed_orcids":["https://orcid.org/0000-0002-0650-9698"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jeffrey A. Sosman","raw_affiliation_strings":["Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Ave, Nashville, TN 37232, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Ave, Nashville, TN 37232, USA","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025067315","display_name":"Douglas Buckner Johnson","orcid":"https://orcid.org/0000-0002-6390-773X","observed_orcids":["https://orcid.org/0000-0002-6390-773X"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas B. Johnson","raw_affiliation_strings":["Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Ave, Nashville, TN 37232, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University School of Medicine, Vanderbilt-Ingram Cancer Center, 2220 Pierce Ave, Nashville, TN 37232, USA","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5075566772"],"corresponding_institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.01649366,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"67","last_page":"84"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8880000114440918},{"id":"https://openalex.org/keywords/braf-v600-mutation","display_name":"BRAF V600 mutation","score":0.9539999961853027},{"id":"https://openalex.org/keywords/braf-inhibitors","display_name":"BRAF inhibitors","score":0.9559999704360962},{"id":"https://openalex.org/keywords/vemurafenib","display_name":"vemurafenib","score":0.9940000176429749},{"id":"https://openalex.org/keywords/dabrafenib","display_name":"dabrafenib","score":1.0},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.8679999709129333},{"id":"https://openalex.org/keywords/trametinib","display_name":"trametinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8069999814033508},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.9200000166893005},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.8519999980926514}],"concepts":[{"id":"https://openalex.org/C2778830669","wikidata":"https://www.wikidata.org/wiki/Q3011604","display_name":"Dabrafenib","level":5,"score":0.9640722274780273},{"id":"https://openalex.org/C2778472372","wikidata":"https://www.wikidata.org/wiki/Q7833138","display_name":"Trametinib","level":4,"score":0.9570861458778381},{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.9409225583076477},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6812011003494263},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6675716638565063},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.6056840419769287},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5144784450531006},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.5106626152992249},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.48069435358047485},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4356550872325897},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3827795684337616},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3263590931892395},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.29252463579177856},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.1752658188343048},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.15518945455551147},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.13676980137825012},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.10897457599639893},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.05214253067970276}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1007/978-1-4939-2143-0_4","doi":"https://doi.org/10.1007/978-1-4939-2143-0_4","is_oa":false,"landing_page_url":"https://doi.org/10.1007/978-1-4939-2143-0_4","pdf_url":null,"source":{"id":"https://openalex.org/S4210186866","display_name":"Cancer drug discovery and develogment/Cancer drug discovery and development","issn_l":"2196-9906","issn":["2196-9906","2196-9914"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20"],"host_organization":"https://openalex.org/P4310319972","host_organization_name":"Springer International Publishing","host_organization_lineage":["https://openalex.org/P4310319972","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer International Publishing","Springer Nature"],"type":"book series"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Drug Discovery and Development","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W1967835627","https://openalex.org/W1970845550","https://openalex.org/W1988079950","https://openalex.org/W1988379285","https://openalex.org/W1990011632","https://openalex.org/W1999025555","https://openalex.org/W2003127157","https://openalex.org/W2006741643","https://openalex.org/W2011042089","https://openalex.org/W2013178885","https://openalex.org/W2017187984","https://openalex.org/W2022053622","https://openalex.org/W2025798292","https://openalex.org/W2031278548","https://openalex.org/W2032211985","https://openalex.org/W2034048944","https://openalex.org/W2043058822","https://openalex.org/W2053473615","https://openalex.org/W2055624262","https://openalex.org/W2058390096","https://openalex.org/W2068882576","https://openalex.org/W2091100650","https://openalex.org/W2100969832","https://openalex.org/W2103845135","https://openalex.org/W2105660237","https://openalex.org/W2106494998","https://openalex.org/W2106543129","https://openalex.org/W2108537717","https://openalex.org/W2111317901","https://openalex.org/W2116952549","https://openalex.org/W2125333956","https://openalex.org/W2128327828","https://openalex.org/W2128542677","https://openalex.org/W2131040858","https://openalex.org/W2134148782","https://openalex.org/W2136474966","https://openalex.org/W2136925048","https://openalex.org/W2139684524","https://openalex.org/W2141674733","https://openalex.org/W2141830999","https://openalex.org/W2150669821","https://openalex.org/W2155461614","https://openalex.org/W2156078931","https://openalex.org/W2163188200","https://openalex.org/W2164996207","https://openalex.org/W2166262263","https://openalex.org/W2168143310","https://openalex.org/W2212772780","https://openalex.org/W2520540679","https://openalex.org/W2591544462","https://openalex.org/W2598403415","https://openalex.org/W2787145482"],"related_works":["https://openalex.org/W2026160531","https://openalex.org/W2025130458","https://openalex.org/W2052781279","https://openalex.org/W2947157850","https://openalex.org/W2335844855","https://openalex.org/W7163522211","https://openalex.org/W1019048771","https://openalex.org/W2571465038","https://openalex.org/W2025069507","https://openalex.org/W2409176294"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2016-06-24T00:00:00"}